Anthony Coulson, our Creative Head of Design Implementation, recently celebrated 10 years of working at AS&K. We asked him about the highlights.
You celebrated 10 years at AS&K recently. A decade is a long time – what have been your highlights?
The use of AI to aid diagnosis has been heralded increasingly often as an imminent evolution in the world of gastroenterology (1, 2). Thanks to an Italian study, in April the FDA has approved for the first time a tool for colonoscopy that helps doctors detect suspicious lesions in real time whilst performing the examination (3, 4).
The pharmaceutical industry gets a lot of bad press. Much of it is admittedly deserved; when you are in the business of putting stuff into people’s bodies, the slightest unethical behaviour must be dealt with, rapidly and transparently.
We’re committed to doing all we can to reduce our carbon footprint – at home as well as for our clients. One way we’re doing this internally is by offering our staff a salary sacrifice scheme for electric cars. This is a government scheme that allows people to lease a new electric car with payments from gross salary, before tax and national insurance, thus making a substantial saving.
A dream of science fiction writers until a few decades ago, artificial intelligence (AI) has become an integral part of our existence, with a particularly prominent role in healthcare – as a tool to both manage and analyse information and to assist diagnosis and follow-up in several therapy areas. Its involvement in medical writing was therefore bound to be the next natural step.